Health Canada drug identification number

DIN 02561476 — RECOMBIVAX HB 5 MCG

RECOMBIVAX HB is a solution of Hepatitis B Surface Antigen marketed by MERCK CANADA INC. The full Hepatitis B Surface Antigen monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02561476
Brand name
RECOMBIVAX HB
Strength
5 MCG
Dosage form
SOLUTION
Route
INTRAMUSCULAR
Manufacturer
MERCK CANADA INC
Health Canada status
MARKETED
Drug class
Recombinant viral subunit vaccine

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Hepatitis B Surface Antigen products

DINBrandStrengthFormManufacturerStatus
02487020 ENGERIX-B 10 MCG SUSPENSION GLAXOSMITHKLINE INC MARKETED
02487039 ENGERIX-B 20 MCG SUSPENSION GLAXOSMITHKLINE INC MARKETED
02561484 RECOMBIVAX HB 10 MCG SOLUTION MERCK CANADA INC MARKETED
02245977 RECOMBIVAX HB 40 MCG SUSPENSION MERCK CANADA INC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.